List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Pediatric Neuroblastoma Treatment Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Pediatric Neuroblastoma Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pediatric Neuroblastoma Treatment Market Size for the Year 2017-2028
1.2.2 Global Pediatric Neuroblastoma Treatment Market Size for the Year 2017-2028
1.3 Pediatric Neuroblastoma Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Pediatric Neuroblastoma Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Pediatric Neuroblastoma Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Pediatric Neuroblastoma Treatment Market Dynamics
1.4.1 Pediatric Neuroblastoma Treatment Industry Trends
1.4.2 Pediatric Neuroblastoma Treatment Market Drivers
1.4.3 Pediatric Neuroblastoma Treatment Market Challenges
1.4.4 Pediatric Neuroblastoma Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Pediatric Neuroblastoma Treatment by Type
2.1 Pediatric Neuroblastoma Treatment Market Segment by Type
2.1.1 Immunotherapy
2.1.2 Chemotherapy
2.1.3 Others
2.2 Global Pediatric Neuroblastoma Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Pediatric Neuroblastoma Treatment Market Size by Type (2017-2028)
2.4 United States Pediatric Neuroblastoma Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Pediatric Neuroblastoma Treatment Market Size by Type (2017-2028)
3 Pediatric Neuroblastoma Treatment by Application
3.1 Pediatric Neuroblastoma Treatment Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Pediatric Neuroblastoma Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Pediatric Neuroblastoma Treatment Market Size by Application (2017-2028)
3.4 United States Pediatric Neuroblastoma Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Pediatric Neuroblastoma Treatment Market Size by Application (2017-2028)
4 Global Pediatric Neuroblastoma Treatment Competitor Landscape by Company
4.1 Global Pediatric Neuroblastoma Treatment Market Size by Company
4.1.1 Top Global Pediatric Neuroblastoma Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Pediatric Neuroblastoma Treatment Revenue by Player (2017-2022)
4.2 Global Pediatric Neuroblastoma Treatment Concentration Ratio (CR)
4.2.1 Pediatric Neuroblastoma Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Pediatric Neuroblastoma Treatment in 2021
4.2.3 Global Pediatric Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pediatric Neuroblastoma Treatment Headquarters, Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Pediatric Neuroblastoma Treatment Headquarters and Area Served
4.3.2 Global Pediatric Neuroblastoma Treatment Companies Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Pediatric Neuroblastoma Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Pediatric Neuroblastoma Treatment Market Size by Company
4.5.1 Top Pediatric Neuroblastoma Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pediatric Neuroblastoma Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Pediatric Neuroblastoma Treatment Market Size by Region
5.1 Global Pediatric Neuroblastoma Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pediatric Neuroblastoma Treatment Market Size by Region (2017-2028)
5.2.1 Global Pediatric Neuroblastoma Treatment Market Size by Region: 2017-2022
5.2.2 Global Pediatric Neuroblastoma Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pediatric Neuroblastoma Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Pediatric Neuroblastoma Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pediatric Neuroblastoma Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Pediatric Neuroblastoma Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pediatric Neuroblastoma Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Pediatric Neuroblastoma Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pediatric Neuroblastoma Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pediatric Neuroblastoma Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 United Therapeutics
7.1.1 United Therapeutics Company Details
7.1.2 United Therapeutics Business Overview
7.1.3 United Therapeutics Pediatric Neuroblastoma Treatment Introduction
7.1.4 United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.1.5 United Therapeutics Recent Development
7.2 Apeiron Biologics
7.2.1 Apeiron Biologics Company Details
7.2.2 Apeiron Biologics Business Overview
7.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Introduction
7.2.4 Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.2.5 Apeiron Biologics Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Details
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Pediatric Neuroblastoma Treatment Introduction
7.3.4 Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.3.5 Pfizer Recent Development
7.4 Bayer
7.4.1 Bayer Company Details
7.4.2 Bayer Business Overview
7.4.3 Bayer Pediatric Neuroblastoma Treatment Introduction
7.4.4 Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.4.5 Bayer Recent Development
7.5 Baxter
7.5.1 Baxter Company Details
7.5.2 Baxter Business Overview
7.5.3 Baxter Pediatric Neuroblastoma Treatment Introduction
7.5.4 Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.5.5 Baxter Recent Development
7.6 Cellectar Biosciences
7.6.1 Cellectar Biosciences Company Details
7.6.2 Cellectar Biosciences Business Overview
7.6.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Introduction
7.6.4 Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.6.5 Cellectar Biosciences Recent Development
7.7 MacroGenics
7.7.1 MacroGenics Company Details
7.7.2 MacroGenics Business Overview
7.7.3 MacroGenics Pediatric Neuroblastoma Treatment Introduction
7.7.4 MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.7.5 MacroGenics Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
